Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00751634 · ClinicalTrials.gov registry record · Phase 4
Temperature Control in Central Fever in the Neuro-ICU
A Phase 4 study of Fever and Brain Hemorrhage, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00751634: Completed Phase 4 study of Fever and Brain Hemorrhage, sponsored by Northwestern University.
NCT00751634 is a Phase 4 study of Fever and Brain Hemorrhage that has completed, run by Northwestern University. The registered enrollment target is 20 participants, below the 598-participant average among 18 other Fever trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00751634, a Phase 4 study of Fever and Brain Hemorrhage, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket will reduce temperature in neurologically ill patients with central fever.
Primary Outcome
Core temperature (in degrees Fahrenheit, F) throughout the study period. The cooling blanket was in place throughout the study period unless severe shivering led to termination per protocol.
Conditions Studied
Interventions
- DEVICE Gaymar Rapr-Round (external cooling blanket)
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-01 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
What the finished NCT00751634 record still lists
NCT00751634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 598-participant average among 18 other Fever trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Fever appearing as the primary indexed condition, and to 1 intervention - of which Gaymar Rapr-Round (external cooling blanket) is the first listed.
NCT00751634 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00751634 about?
NCT00751634 is a clinical study titled "Temperature Control in Central Fever in the Neuro-ICU". There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket will reduce temperature in neurologically ill patients with central fever.
What is the current status of trial NCT00751634?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2009-01. Estimated completion is 2011-01.
What conditions does trial NCT00751634 study?
This clinical trial studies the following conditions: Fever, Brain Hemorrhage.
What interventions are being tested in trial NCT00751634?
The interventions under investigation include: Gaymar Rapr-Round (external cooling blanket) (DEVICE).
Who is sponsoring clinical trial NCT00751634?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00751634 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fever
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00751634's enrollment target sits among peer trials
20 17th of 18 higher than 2 of 18 other Fever trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fever trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety of RSV Preventive Monoclonal Antibody
RECRUITING · Phase 4
-
Ibuprofen Alone and in Combination With Acetaminophen for Treatment of Fever
COMPLETED · Phase 4
-
Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
COMPLETED · Phase 4
-
Clinical Immunization Safety Assessment (CISA) Project: Pilot Study to Assess the Effect of Prophylactic Antipyretics on Immune Responses and Fever After IIV
COMPLETED · Phase 4
-
TriVerity™ for Improved Management of Emergency Department (ED) Patients With Suspected Infections
RECRUITING · NA
-
Remote Temperature Monitoring of Patients At Risk for Developing Fever
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia